insights_auto
Outlook: 37.5% bullish·12.5% bearish
Go to analysischevron_right
AMGN34:BVMF
Amgen Inc. BDR
85,23 BRL
0,00%
(0,00) 1D
27-окт., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
84,37 BRL
High
85,39 BRL
Low
83,79 BRL
Mkt. cap
242,18 млд
Avg. vol.
401,00
Volume
65,00
52-wk high
85,84 BRL
52-wk low
47,76 BRL
Shares outstanding
540,63 млн
No. of employees
32 миң
Open
84,37 BRL
High
85,39 BRL
Low
83,79 BRL
Mkt. cap
242,18 млд
Avg. vol.
401,00
Volume
65,00
52-wk high
85,84 BRL
52-wk low
47,76 BRL
Shares outstanding
540,63 млн
No. of employees
32 миң
News stories
From web sources and news partners
Amgen
·
1 саат мурун
AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND
Yahoo Finance
·
4 саат мурун
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
Investor's Business Daily
·
5 саат мурун
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
The Motley Fool
·
8 саат мурун
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 миң
Founded1980
HeadquartersТаусанд Окс, Калифорния, Америка Кошмо Штаттары
Sector-
Websiteamgen.com